• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Virtus LifeSci Biotech Clinical Trials ETF (NY:BBC)

39.05 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6
Open 39.05
Bid (Size) 15.71 (100)
Ask (Size) 62.08 (100)
Prev. Close 39.05
Today's Range 39.05 - 39.05
52wk Range 13.42 - 40.82
Shares Outstanding 4,000
Dividend Yield 1.68%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Did GLUE Stock Surge Over 50% In Premarket Today? ↗
January 07, 2026
Monte Rosa Therapeutics reported positive interim Phase 1 data for MRT-8102, showing significant anti-inflammatory effects in patients with elevated cardiovascular risk. 
Via Stocktwits
News headline image
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation ↗
May 07, 2025
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns. 
Via Benzinga

Performance

YTD
+3.8%
+3.8%
1 Month
-0.8%
-0.8%
3 Month
+31.7%
+31.7%
6 Month
+81.4%
+81.4%
1 Year
+60.9%
+60.9%

More News

Read More
News headline image
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On ↗
April 28, 2025
Via Benzinga
Topics ETFs Economy Stocks
News headline image
CureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch Mode ↗
April 10, 2025
Via Stocktwits
Topics Government
News headline image
Why Is uniQure Stock Skyrocketing On Tuesday? ↗
December 10, 2024
Via Benzinga
News headline image
Inflation Cools In June, Triggers Spike In Laggard ETFs ↗
July 12, 2024
Via Talk Markets
Topics ETFs Economy
News headline image
5 ETFs Riding High On The Biotech Comeback ↗
July 09, 2022
Via Talk Markets
News headline image
Biotech ETF Tops in June: 5 Stocks That Outperform ↗
June 30, 2022
Via Talk Markets
News headline image
4 Sector ETFs That Survived Market Turmoil in June ↗
June 29, 2022
Via Talk Markets

Frequently Asked Questions

Is Virtus LifeSci Biotech Clinical Trials ETF publicly traded?
Yes, Virtus LifeSci Biotech Clinical Trials ETF is publicly traded.
What exchange does Virtus LifeSci Biotech Clinical Trials ETF trade on?
Virtus LifeSci Biotech Clinical Trials ETF trades on the New York Stock Exchange
What is the ticker symbol for Virtus LifeSci Biotech Clinical Trials ETF?
The ticker symbol for Virtus LifeSci Biotech Clinical Trials ETF is BBC on the New York Stock Exchange
What is the current price of Virtus LifeSci Biotech Clinical Trials ETF?
The current price of Virtus LifeSci Biotech Clinical Trials ETF is 39.05
When was Virtus LifeSci Biotech Clinical Trials ETF last traded?
The last trade of Virtus LifeSci Biotech Clinical Trials ETF was at 01/08/26 08:00 PM ET
What is the market capitalization of Virtus LifeSci Biotech Clinical Trials ETF?
The market capitalization of Virtus LifeSci Biotech Clinical Trials ETF is 156.20K
How many shares of Virtus LifeSci Biotech Clinical Trials ETF are outstanding?
Virtus LifeSci Biotech Clinical Trials ETF has 156K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap